Cases and resources in vascular techniques

Intermittent claudication significantly affects quality of life, but the benefits of endovascular treatment remain uncertain. While paclitaxel-coated devices reduce restenosis, safety concerns emerged after a 2018 meta-analysis suggested higher long-term mortality. The SWEDEPAD 2 trial compared coated and uncoated devices to evaluate safety and patient-centred outcomes in infrainguinal revascularisation.

Carotid stenosis without visible atheromatous plaque raises diagnostic and therapeutic challenges, especially in patients with complex medical backgrounds. This case presents an uncommon scenario of subocclusive carotid stenosis in a woman with a history of breast cancer and prior radiotherapy, inviting reflection on the potential role of radiation-induced vascular injury.

Prof. Peter Schneider and Dr. Fabien Lareyre explore the carotid chapter of the 2025 PVI Trials Book, highlighting key trials on symptomatic and asymptomatic disease, emerging topics such as cryptogenic stroke, and the potential impact of AI in imaging and plaque analysis. They discuss pivotal studies including ACST-2, a dementia-focused analysis, and the upcoming CREST-2 trial, showing why the Trials Book remains an essential reference for vascular specialists.

Pharmacist-led review improves best medical treatment (BMT) in patients with vascular disease. In 258 patients, it increased high-intensity statin prescribing and, among smokers, boosted nicotine replacement therapy and cessation service referrals. Antiplatelet therapy was unchanged. These interventions may enhance BMT adherence, reduce costs, and free specialist time, addressing persistent underprescription despite guideline recommendations.

Prof. Resch and Dr. Raffort-Lareyre explore the aortic chapter of the PVI Trials Book, highlighting pivotal studies—STAGED-FEVAR, META-TAAA, SEXAAA, and UK-COMPASS—that are shaping modern endovascular and aortic practice. Discover how these trials influence clinical decisions and why the Trials Book remains an essential guide for vascular specialists.

Pelvic venous disorders are becoming an increasingly important topic in vascular care. In this interview, Dr. Jorinde van Laanen and Dr. Diego Ruiz Chiriboga cover patient pathways, multidisciplinary approaches, the upcoming updated Trials Book chapter, current studies including coiling of incompetent veins, and dedicated sessions on pelvic disorders. A must-watch for clinicians looking to stay on top of this evolving field.

A 72-year-old patient with severe left carotid stenosis and contralateral occlusion raises a critical treatment challenge. Discover the case details and join the discussion on revascularisation strategy and device selection.

A rare, aggressive AV malformation in a 7-day-old baby, diagnosed as Kaposiform hemangioendothelioma, poses a high risk of rapid growth and severe bleeding. What treatment offers the best chance to control this life-threatening condition?

What’s the best way to tackle femoropopliteal lesions today? Prof. Grigorios Korosoglou shares the key points of a new algorithm designed to guide lesion preparation and treatment choices. Based on patient condition, lesion type, and crossing technique, this expert-backed framework helps clarify when to use tools like atherectomy, lithotripsy, or DES. Get the essentials in just a few minutes!

Prof. Athanasios Saratzis highlights key gaps and new directions in PAD research with recent and upcoming RCTs.